Licenses aim to accelerate drug discovery leading to development of new therapies PanCELLa agreement marks MilliporeSigma’s first CRISPR license for bioproduction Takara Bio USA agreement gives access to MilliporeSigma’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two […]
Berlin, Germany – Bruker and Oxford Instruments have announced that they have reached a settlement on a patent related issue with Bruker’s Cube product. The agreement licences Bruker the Oxford Instruments patents relating to the design of low noise charge sensitive amplifiers (CSAs) of which Cube is an example. These CSAs are key components in […]
Oxford Instruments plc and Bruker Corporation have announced that they have reached a settlement on a patent related issue with Bruker’s Cube product. The agreement licences Bruker the Oxford Instruments patents relating to the design of low noise charge sensitive amplifiers (CSAs) of which Cube is an example. These CSAs, are key components in a […]
Patent strengthens company’s intellectual property protection and expands portfolio FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, today announced that the company was recently awarded a patent by the United States Patent and Trademark Office for the “Combined Lysis Protocol for Comprehensive Cell […]
ERS Genomics provides comment on US patent office motions decisions in CRISPR/Cas9 interference case
DUBLIN, Ireland: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, has today provided comment on the US Patent and Trademark Office (USPTO/PTAB) rulings in the motions phase of the ongoing patent interference between the University of California, the University of Vienna, and Dr. […]
VANCOUVER, British Columbia, Aug 25, 2020 (GLOBE NEWSWIRE via COMTEX) — Lighthouse Genomics Inc. (“Lighthouse” or the “Company”), announces filing a US patent application and Canadian trademark applications in the months of July and August. The new Intellectual Property (IP) holdings expand the company’s protection to operate with key branding and methods in the fast-growing […]
Regarding the patent lawsuit initiated by Illumina against MGI in Hong Kong, the specific impact has yet to be determined. MGI believes that this patent litigation is an obvious attempt by Illumina to maintain a monopolistic market position and suppress the development of the industry. We intend to vigorously defend our intellectual property, and we have filed patent litigation against […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder). On August 13, 2020, BioSpyder filed a lawsuit seeking a declaration that it does not infringe HTG’s U.S. Patent No. 8,741,564 (the ’564 patent). In […]
CARLSBAD, Calif.–On Wednesday, August 12, 2020, BioSpyder Technologies, Inc. (“BioSpyder”) filed a civil action in the federal court for the Northern District of California, seeking a declaratory judgment that the BioSpyder TempO-Seq gene expression profiling assay does not infringe any valid claim in U.S. Patent No. 8,741,564 (“the ’564 patent”) for Quantitative Nuclease Protection Assay […]
HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the The United States Court of Appeals for the Federal Circuit today affirmed that 10x Genomics willfully infringed U.S. Patent 8,889,083, exclusively licensed to Bio-Rad from the University of Chicago. The Appeals Court upheld […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
